Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether it is his Department's policy that vaccines should be mixed in the event that a recipient of one dose of the AstraZeneca covid-19 vaccine subsequently experiences a blood clotting condition.
Public Health England’s Green Book, which provides COVID-19 vaccination information for public health professionals, advises that individuals who are suspected of having experienced a clotting episode with concomitant thrombocytopaenia following the first dose of the Oxford/AstraZeneca vaccine should be properly assessed. If they are considered to have the condition, further vaccination should be deferred until their clotting has completely stabilised and they should then be considered for a second dose of an alternative COVID-19 vaccine.